Skeletalis: Funding, Investors & Team (Sep 2026)
Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures safely.
Skeletalis has raised $8.0M across 1 funding round on record, the most recent a Seed of $8.0M announced in Nov 2025.
That round is below the $15M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Skeletalis Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Skeletalis Funding Rounds
Skeletalis Founders and Leadership Team
Contact details for the Skeletalis team: 1 has a LinkedIn profile.
Start 14-day free trial →Skeletalis Funding Compared to Other Biotechnology Startups
Skeletalis' latest round of $8.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Skeletalis in Biotechnology and Boston
Companies Similar to Skeletalis
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific…
Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading…
Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.
Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and…
Excellergy develops portfolio of trifunctional effector cell response inhibitors (ECRIs) to combat severe…
Curadel Surgical Innovations oversees the complete process of Curadel's FLARE contrast agents for…
Ventuno Biotech is a biotech company that is developing innovative cancer therapies.
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the…
Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies
Treating the seeds of cancer
Nuclide Therapeutics provides radiopharmaceutical medicines that combine nuclear medicine and biotechnology.
Skeletalis Funding FAQs
What does Skeletalis do?
Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures safely.
How much funding has Skeletalis raised?
Skeletalis has raised $8.0M across 1 round on record. The most recent is a Seed of $8.0M announced in Nov 2025.
When did Skeletalis last raise funding?
Skeletalis' most recent funding round on record is a Seed of $8.0M, announced in Nov 2025.
Who founded Skeletalis?
FundedIQ lists W Benton Swanson (Founder) at Skeletalis.
Where is Skeletalis headquartered?
Skeletalis is based in Boston, United States.
How many employees does Skeletalis have?
Skeletalis is in the 1-10 employee band.
How does Skeletalis' funding compare to other Biotechnology startups?
Skeletalis' latest round of $8.0M is below the $15M median round size for Biotechnology companies on FundedIQ across 16 tracked companies over the last two years.
About FundedIQ's Skeletalis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Skeletalis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.